Engimmune Therapeutics’ CHF 15.5 Million Seed Financing Round

Walder Wyss advised Engimmune Therapeutics on the deal. Vischer advised the investors Pureos Bio-ventures and Novo Holdings.Engimmune Therapeutics completed a CHF 15.5m seed financing round co-led by…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now